Monday, November 13, 2023
- 9:00AM-11:00AM
-
Abstract Number: 0951
Single Cell Analysis of Transitional B Cells in Systemic Sclerosis Highlights Defective Peripheral Tolerance
(0934–0964) Systemic Sclerosis & Related Disorders – Basic Science Poster- 9:00AM-11:00AM
-
Abstract Number: 0859
Single Injection AAV2-hFGF18 Demonstrates Superior Safety and Efficacy over Repeat rhFGF18 Protein Injections in a Model of Induced Osteoarthritis
(0859–0885) Osteoarthritis & Joint Biology – Basic Science Poster- 9:00AM-11:00AM
-
Abstract Number: 0926
Single-cell Multi-Omic Evaluation of Differences in Immune Cell Populations in Progression Toward Systemic Lupus Erythematosus
(0899–0933) SLE – Etiology & Pathogenesis Poster- 9:00AM-11:00AM
-
Abstract Number: 0892
Single-Cell RNA Sequencing Reveals Keratinocytes and Fibroblasts Drive Hippo and TGFb Dysregulation and Fibrosis in Epidermal Overexpression of VGLL3 in Cutaneous Lupus
(0886–0898) SLE – Animal Models Poster- 9:00AM-11:00AM
-
Abstract Number: 1027
Single-Payer Health Insurance May Not Mitigate Income-Based Differences in Total Hip Arthroplasty Utilization: A Transnational Analysis
(1013–1032) Healthcare Disparities in Rheumatology Poster II: Socioeconomic Determinants- 9:00AM-11:00AM
-
Abstract Number: 1220
Sjögren’s Patients’ Experiences and Content Validity of the Dry Eye Disease Symptom Questionnaire (DED-SQ)
(1200–1220) Patient Outcomes, Preferences, & Attitudes Poster II- 9:00AM-11:00AM
-
Abstract Number: 1376
SJOGRENSER Registry: Prospective Evaluation of a Cohort of Patients with Primary Sjögren’s Syndrome After 8 Years of Follow-up
(1365–1382) Sjögren’s Syndrome – Basic & Clinical Science Poster I- 9:00AM-11:00AM
-
Abstract Number: 0928
Skewing of B Cell Receptor Repertoire in Unswitched Memory B Cells Is Associated with Disease Activity of Systemic Lupus Erythematosus and Targeted by Belimumab
(0899–0933) SLE – Etiology & Pathogenesis Poster- 9:00AM-11:00AM
-
Abstract Number: 1445
SLESIS-R: An Improved Score for Prediction of Serious Infection in Patients with Systemic Lupus Erythematosus Based on the RELESSER Prospective Cohort
(1442–1487) SLE – Diagnosis, Manifestations, & Outcomes Poster II- 9:00AM-11:00AM
-
Abstract Number: 1029
Social Determinants of Health in Children with Rheumatic Disease: A Single Center Cohort
(1013–1032) Healthcare Disparities in Rheumatology Poster II: Socioeconomic Determinants- 9:00AM-11:00AM
-
Abstract Number: 0935
Sodium Pyruvate Improves Mitochondrial Fitness in SSc Fibroblasts to Prevent Fibroblast-to-myofibroblast Transition and Fibrotic Remodeling
(0934–0964) Systemic Sclerosis & Related Disorders – Basic Science Poster- 9:00AM-11:00AM
-
Abstract Number: 1185
Soluble Buffered Alendronate After Denosumab Discontinuation in Erosive Hand OA Patients
(1183–1199) Osteoarthritis – Clinical Poster II- 9:00AM-11:00AM
-
Abstract Number: 0911
Spatial Transcriptomics Reveals Normal-density and Low-density Neutrophils Are More Prevalent Than Macrophages in Lupus Nephritis Glomeruli, and Urine DNA Methylation Analyses Capture Both Myeloid Populations
(0899–0933) SLE – Etiology & Pathogenesis Poster- 9:00AM-11:00AM
-
Abstract Number: 0890
Specificity of Brain-Intrinsic and Hematopoietic-Derived Mechanisms in Mediating Neuropsychiatric Symptoms of Systemic Lupus Erythematosus